美国 · SEC FORM 4
Orchestra BioMed Holdings, Inc.
OBIO · Nasdaq · CIK 0001814114 · Healthcare · Biotechnology
内部人信号
当前没有活跃买入信号
7 qualifying P purchase groups
当前 180 天评分窗口
36 同一窗口内观察到的 Form 4 交易行
6 sales · 23 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2026-09-03 · Hochman David P · $47.9K
为什么没有活跃信号？
买入活动存在
近期买入7 qualifying line group(s)
近期卖出中等
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度与集中度
合资格买方4
买入集中度40%最大买方： Hochman David P · $85.9K
聚集买入 · 15天3 insiders峰值活动： 2026-05-14–2026-05-18
Roles in the peak window: Director, See Remarks. Concentration uses priced qualifying P lines only and does not change the saved score.
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Sherman DarrenSee Remarks
○▼▼▼○●▼▼
Hochman David PSee Remarks
●●○○●○○
Fain Eric SDirector
●○○○
Pacitti DavidDirector
○○○
Mack John ProsperDirector
○○○
Taylor Andrew LawrenceChief Financial Officer
○○○
● 买入▼ 卖出○ 其他
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-09-03 · Hochman David P.
近期 Form 4 活动
9买入
6卖出
40其他 Form 4 交易行
46SEC 申报 · 365天
买入7 qualifying P line(s) · 180 days
卖出6 sale line(s) · 仅供背景
其他23 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,547,249
- 上期报告
- 2,372,557
- 日均成交量
- 364,835
- 回补天数
- 7.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Hochman David P | 买入 (P) | Common Stock, par value $0.0001 per share ("Common Stock") | 10,000 | USD 4.79 | USD 47,900 | SEC 申报 ↗ |
| 2026-08-26 | Sherman Darren | 买入 (P) | Common Stock | 2,000 | USD 5.33 | USD 10,660 | SEC 申报 ↗ |
| 2026-06-01 | Hochman David P | 买入 (P) | Common Stock, par value $0.0001 per share ("Common Stock") | 5,000 | USD 3.83 | USD 19,150 | SEC 申报 ↗ |
| 2026-05-18 | Aryeh Jason | 买入 (P) | Common Stock, par value $0.0001 per share | 665 | USD 3.75 | USD 2,494 | SEC 申报 ↗ |
| 2026-05-15 | Hochman David P | 买入 (P) | Common Stock, par value $0.0001 per share ("Common Stock") | 5,000 | USD 3.77 | USD 18,850 | SEC 申报 ↗ |
| 2026-05-15 | Aryeh Jason | 买入 (P) | Common Stock, par value $0.0001 per share | 8,971 | USD 3.90 | USD 34,987 | SEC 申报 ↗ |
| 2026-05-14 | Fain Eric S | 买入 (P) | Common Stock, par value $0.0001 per share | 20,000 | USD 4.13 | USD 82,600 | SEC 申报 ↗ |
| 2026-03-13 | Hochman David P | 买入 (P) | Common Stock, par value $0.0001 per share ("Common Stock") | 10,000 | USD 4.29 | USD 42,900 | SEC 申报 ↗ |
| 2025-11-14 | Hochman David P | 买入 (P) | Common Stock, par value $0.0001 per share ("Common Stock") | 5,000 | USD 4.07 | USD 20,350 | SEC 申报 ↗ |
| 2025-09-19 | Aryeh Jason | 买入 (P) | Common Stock, par value $0.0001 per share | 1,000 | USD 2.45 | USD 2,450 | SEC 申报 ↗ |
| 2025-08-25 | Taylor Andrew Lawrence | 买入 (P) | Common Stock, par value $0.0001 per share | 2,000 | USD 2.55 | USD 5,100 | SEC 申报 ↗ |
| 2025-08-25 | Sherman Darren | 买入 (P) | Common Stock, par value $0.0001 per share | 3,000 | USD 2.62 | USD 7,860 | SEC 申报 ↗ |
| 2025-08-25 | Fain Eric S | 买入 (P) | Common Stock, par value $0.0001 per share | 5,760 | USD 2.61 | USD 15,034 | SEC 申报 ↗ |
| 2025-08-21 | Hochman David P | 买入 (P) | Common Stock, par value $0.0001 per share ("Common Stock") | 6,000 | USD 2.49 | USD 14,940 | SEC 申报 ↗ |
| 2025-08-04 | Hochman David P | 买入 (P) | Common Stock, par value $0.0001 per share ("Common Stock") | 20,000 | USD 2.75 | USD 55,000 | SEC 申报 ↗ |
Form 4 申报证据
55 transaction lines in the latest 365-day window; 189 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Sherman Darren | 卖出 (S) | Common Stock, par value $0.0001 per share ("Common Stock") | 15,000 | USD 6.36 | USD 95,400 | SEC 申报 ↗ |
| 2026-09-10 | Hochman David P | 代扣税 (F) | Common Stock, par value $0.0001 per share ("Common Stock") | 3,283 | USD 5.81 | USD 19,074 | SEC 申报 ↗ |
| 2026-09-10 | Hochman David P | 代扣税 (F) | Common Stock | 3,283 | USD 5.81 | USD 19,074 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Sherman Darren | 卖出 (S) | Common Stock, par value $0.0001 per share ("Common Stock") | 15,000 | USD 6.36 | USD 95,400 | SEC 申报 ↗ |
| 2026-09-10 | Hochman David P | 代扣税 (F) | Common Stock, par value $0.0001 per share ("Common Stock") | 3,283 | USD 5.81 | USD 19,074 | SEC 申报 ↗ |
| 2026-09-10 | Hochman David P | 代扣税 (F) | Common Stock | 3,283 | USD 5.81 | USD 19,074 | SEC 申报 ↗ |
| 2026-09-03 | Hochman David P | 买入 (P) | Common Stock, par value $0.0001 per share ("Common Stock") | 10,000 | USD 4.79 | USD 47,900 | SEC 申报 ↗ |
| 2026-09-01 | Sherman Darren | 卖出 (S) | Common Stock, par value $0.0001 per share ("Common Stock") | 15,000 | USD 4.94 | USD 74,100 | SEC 申报 ↗ |
| 2026-08-26 | Taylor Andrew Lawrence | 代扣税 (F) | Common Stock, par value $0.0001 per share | 3,076 | USD 5.26 | USD 16,180 | SEC 申报 ↗ |
| 2026-08-26 | Sherman Darren | 买入 (P) | Common Stock | 2,000 | USD 5.33 | USD 10,660 | SEC 申报 ↗ |
| 2026-08-26 | Sherman Darren | 代扣税 (F) | Common Stock, par value $0.0001 per share ("Common Stock") | 4,925 | USD 5.26 | USD 25,906 | SEC 申报 ↗ |
| 2026-08-26 | Aiello Joshua | 代扣税 (F) | Common Stock, par value $0.0001 per share | 203 | USD 5.26 | USD 1,068 | SEC 申报 ↗ |
| 2026-08-12 | Pacitti David | 代扣税 (F) | Common Stock, par value $0.0001 per share | 3,761 | USD 4.42 | USD 16,624 | SEC 申报 ↗ |
| 2026-08-12 | Mack John Prosper | 代扣税 (F) | Common Stock, par value $0.0001 per share | 4,885 | USD 4.42 | USD 21,592 | SEC 申报 ↗ |
| 2026-08-12 | Fain Eric S | 代扣税 (F) | Common Stock, par value $0.0001 per share | 5,145 | USD 4.42 | USD 22,741 | SEC 申报 ↗ |
| 2026-08-12 | Cleary Chris | 代扣税 (F) | Common Stock, par value $0.0001 per share | 4,238 | USD 4.42 | USD 18,732 | SEC 申报 ↗ |
| 2026-08-03 | Sherman Darren | 卖出 (S) | Common Stock, par value $0.0001 per share | 15,000 | USD 4.09 | USD 61,350 | SEC 申报 ↗ |
| 2026-07-01 | Sherman Darren | 卖出 (S) | Common Stock, par value $0.0001 per share | 15,000 | USD 4.27 | USD 64,050 | SEC 申报 ↗ |
| 2026-06-24 | Pacitti David | 代扣税 (F) | Common Stock | 3,784 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-24 | Mack John Prosper | 代扣税 (F) | Common Stock | 3,510 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-24 | Fain Eric S | 代扣税 (F) | Common Stock | 4,261 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-24 | Cleary Chris | 代扣税 (F) | Common Stock, par value $0.0001 per share | 3,510 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-23 | Pacitti David | 奖励／授予 (A) | Common Stock, par value $0.0001 per share ("Common Stock") | 17,327 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-23 | Mack John Prosper | 奖励／授予 (A) | Common Stock, par value $0.0001 per share ("Common Stock") | 34,653 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-23 | Fain Eric S | 奖励／授予 (A) | Common Stock, par value $0.0001 per share ("Common Stock") | 17,327 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-23 | Connealy Pamela Ann | 奖励／授予 (A) | Common Stock, par value $0.0001 per share ("Common Stock") | 17,327 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-10 | Taylor Andrew Lawrence | 代扣税 (F) | Common Stock, par value $0.0001 per share | 36,352 | USD 4.02 | USD 146,135 | SEC 申报 ↗ |
| 2026-06-10 | Hochman David P | 代扣税 (F) | Common Stock, par value $0.0001 per share ("Common Stock") | 3,283 | USD 4.02 | USD 13,198 | SEC 申报 ↗ |
| 2026-06-10 | Hochman David P | 代扣税 (F) | Common Stock | 3,283 | USD 4.02 | USD 13,198 | SEC 申报 ↗ |
| 2026-06-01 | Sherman Darren | 卖出 (S) | Common Stock, par value $0.0001 per share | 15,000 | USD 3.87 | USD 58,050 | SEC 申报 ↗ |
| 2026-06-01 | Hochman David P | 买入 (P) | Common Stock, par value $0.0001 per share ("Common Stock") | 5,000 | USD 3.83 | USD 19,150 | SEC 申报 ↗ |
| 2026-05-28 | Taylor Andrew Lawrence | 代扣税 (F) | Common Stock, par value $0.0001 per share | 3,076 | USD 3.98 | USD 12,242 | SEC 申报 ↗ |
| 2026-05-28 | Sherman Darren | 代扣税 (F) | Common Stock, par value $0.0001 per share | 4,925 | USD 3.98 | USD 19,602 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | OBIO |
| CIK | 0001814114 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 189 transaction lines from 2020-08-04 to 2026-10-01 37 P purchase lines · 15 S sale lines · 137 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.